An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.
about
Diagnosis and Therapeutic Management of Extra-Intestinal Manifestations of Inflammatory Bowel DiseaseTolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel diseasePain management for inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and other spondyloarthritis) and gastrointestinal or liver comorbiditySelective cyclooxygenase 2 inhibitors for the treatment of rheumatological manifestations of inflammatory bowel diseasePreventive health measures in inflammatory bowel diseaseEnvironmental risk factors for inflammatory bowel diseases: Evidence based literature reviewRole of selective cyclooxygenase-2 inhibitors in exacerbation of inflammatory bowel disease: A systematic review and meta-analysisDrug management of visceral pain: concepts from basic research.Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosisThe joint-gut axis in inflammatory bowel diseases.Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBD Working Group of ESPGHAN.Extraintestinal manifestations and complications in IBD.Pain management in patients with inflammatory bowel disease: translational approaches from bench to bedside.Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease.Non Steroidal Anti-Inflammatory Drugs and Inflammatory Bowel Disease.Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial.Mucosal inflammation in spondylarthritides: past, present, and future.Use of Cyclo-Oxygenase Inhibitors Is Not Associated with Clinical Relapse in Inflammatory Bowel Disease: A Case-Control Study.Management of arthritis in patients with inflammatory bowel diseaseExacerbation of inflammatory bowel disease by nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: fact or fiction?Piroxicam treatment of IL-10-deficient mice enhances colonic epithelial apoptosis and mucosal exposure to intestinal bacteria.FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease.Extraintestinal Manifestations of Inflammatory Bowel Disease.European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
P2860
Q22241416-ACF50D5A-8287-4D05-AB37-F52D13C32667Q24193086-472FD14F-9AE1-4800-8800-70F93D4D25ABQ24203871-68616FFD-790A-433C-AF74-3A5CE5EFD443Q24240479-7EFEB451-8CCC-4EA2-BB69-4668798B6430Q28078112-CF8DCAD5-EC44-4A6D-84AD-794192BD9DB3Q30248747-483DA406-A0A7-4249-9880-853A3AE9B6A0Q35137854-122A28CE-16C8-4FCC-AC9A-783B9252824EQ35947915-C3563025-C174-4FDF-8728-85CD0361711AQ35966079-EDC91BC8-81BA-4882-A2E1-FB0DE48F96C2Q36397893-126B6D0A-5E9E-4614-B6A3-A37344833F46Q37814551-2F725673-CC08-426B-882C-DAAB6FD5ED1EQ37827687-9335C3D7-57C3-4359-A05F-A033856D1F70Q38120146-B9535377-89AD-4BFF-A8A6-FB800F2DD3EAQ38248113-2F1FE4E5-57D2-40CD-84F6-2B0A1585A74BQ38260150-7CA98F93-F35B-4AE7-BF2E-3476E7FC4195Q38974245-02527C1E-B80F-45B9-8740-4ACCCF5BC3FAQ39382693-84519EA1-E20F-4721-ADAB-06AE01C3BB7DQ39730329-EA532436-7848-48EB-B8FC-A9753469C046Q41610897-3A14ADF3-D609-4215-B5BD-D1EC257435B2Q42285921-9D56B5D9-109E-4568-B0A8-EA531DE998C2Q42774113-8BA61365-323D-43B2-AFAD-4AA917A932C7Q46819055-F067272E-6EC2-416B-8D52-D8CB4A6F1417Q51655067-BA9FA6B2-F758-4642-AAA6-71DB062C56D7Q55206226-2BC31F88-8BA8-4E20-827A-4EFECCB2BC6CQ57265399-F105BB17-3A4E-47EE-B390-D00D06B2543E
P2860
An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
An open-label trial of the sel ...... eral arthritis and arthralgia.
@en
An open-label trial of the sel ...... eral arthritis and arthralgia.
@nl
type
label
An open-label trial of the sel ...... eral arthritis and arthralgia.
@en
An open-label trial of the sel ...... eral arthritis and arthralgia.
@nl
prefLabel
An open-label trial of the sel ...... eral arthritis and arthralgia.
@en
An open-label trial of the sel ...... eral arthritis and arthralgia.
@nl
P2093
P2860
P1476
An open-label trial of the sel ...... eral arthritis and arthralgia.
@en
P2093
Lichtenberger C
Miehsler W
Reinisch W
Vogelsang H
Waldhoer T
P2860
P304
P356
10.1046/J.1365-2036.2003.01596.X
P407
P577
2003-06-01T00:00:00Z